• Info
  • Insider Ownership

Insider Trading & Ownership of William D. Young

Location
South San Francisco, CA
Summary
The estimated net worth of William D. Young is at least $802,723 dollars as of 18 Mar 2026. William D. Young is the Director of Theravance Biopharma, Inc. and owns shares of Theravance Biopharma, Inc. (TBPH) stock worth about $802.7K.
Signature
/s/ William Young
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow William D. Young and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to save research and follow filings

Sponsored

Quick Takeaways

  • William D. Young has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $802,723.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Theravance Biopharma, Inc. ($802,723).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of William D. Young

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TBPH Theravance Biopharma, Inc. Director $802,723 26 Apr 2022
AUTL Autolus Therapeutics plc Director 18 Mar 2026
PRAX Praxis Precision Medicines, Inc. Director 26 Jun 2025

Insider Transactions Reported by William D. Young:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored